Novartis to sell majority stake in India unit in ₹1,446 crore deal

The consortium will offer ​Novartis India’s ‌public shareholders ₹860.64 per share, ‌an exchange filing showed, representing a 3.6 per cent ‌premium to ​its closing ​price on Thursday